Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation

被引:1
|
作者
Hagen, Julia M. [1 ]
Sutterland, Arjen L. [1 ]
Schirmbeck, Frederike [1 ,2 ]
Cohn, Danny M. [3 ]
Lok, Anja [1 ,4 ]
Tan, Hanno L. [4 ,5 ,6 ]
Zwinderman, Aeilko H. [7 ]
de Haan, Lieuwe [1 ,2 ,4 ]
机构
[1] Univ Amsterdam, Dept Psychiat, Amsterdam UMC, Amsterdam, Netherlands
[2] Arkin Mental Hlth Inst, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Vasc Med, Amsterdam UMC, Amsterdam, Netherlands
[4] Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands
[5] Univ Amsterdam, Heart Ctr, Dept Cardiol, Amsterdam UMC, Amsterdam, Netherlands
[6] Netherlands Heart Inst, Utrecht, Netherlands
[7] Univ Amsterdam, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam UMC, Amsterdam, Netherlands
关键词
Mood disorders; Anxiety disorders; Advanced glycation end products; Oxidative stress; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; RISK-FACTORS; DSM-IV; DEPRESSION; ANXIETY; ACCUMULATION; ASSOCIATION; MORTALITY;
D O I
10.1016/j.jad.2020.07.108
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Skin autofluorescence (SAF), indicating concentration of advanced glycation end products in the skin and oxidative stress, is cross-sectionally associated with affective disorders. Prospective studies of oxidative stress markers will help to clarify the pathophysiological role of oxidative stress. Methods: Data of a population-based cohort study were used. Presence of major depressive disorder, dysthymia, generalised anxiety disorder, panic disorder or social phobia was assessed at baseline and at 5-year follow-up with the Mini-International Neuropsychiatric Interview. Associations between SAF at baseline and incidence and persistence/recurrence of affective disorders were assessed with logistic regression. Results: Of 43,267 participants with no disorder at baseline, 2885 (6.7%) developed an incident disorder during follow-up. In 1360 of 3648 participants (37.3%) with an affective disorder at baseline, a persisting/recurrent disorder was present at follow-up. A modest association existed between SAF and incident affective disorders (OR=1.07 [95%CI 1.03-1.12], P<.001), specifically major depressive disorder (OR=1.11 [95%CI 1.04-1.19], P=.003); this association lost statistical significance after adjustment for sociodemographic factors. Associations between SAF and persistence/recurrence were not significant. Limitations: Many confounders might also act as intermediate: extensive adjustment for confounders caused overfitting and possibly masked effects of SAF on course of affective disorders. Relatively small sample sizes for analyses of SAF and persistence/recurrence of affective disorders resulted in a low power. Conclusions: Increased SAF modestly raises the odds of incident affective disorders, particularly major depressive disorder, providing evidence that oxidative stress plays a role in subsequent occurrence of affective disorders. However, significance of effects faded after adjustment for socioeconomic status.
引用
收藏
页码:424 / 432
页数:9
相关论文
共 50 条
  • [1] Association between skin autofluorescence of advanced glycation end products and affective disorders in the lifelines cohort study
    Hagen, Julia M.
    Sutterland, Arjen L.
    da Fonseca Pereira de Sousa, Paulo A. L.
    Schirmbeck, Frederike
    Cohn, Danny M.
    Lok, Anja
    Tan, Hanno L.
    Zwinderman, Aeilko H.
    de Haan, Lieuwe
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 275 : 230 - 237
  • [2] Skin autofluorescence of advanced glycation end products and mortality in affective disorders in the lifelines cohort study: A mediation analysis
    Hagen, Julia M.
    Sutterland, Arjen L.
    Liefers, Tessa
    Schirmbeck, Frederike
    Cohn, Danny M.
    Lok, Anja
    Tan, Hanno L.
    Zwinderman, Aeilko H.
    de Haan, Lieuwe
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 282 : 1082 - 1089
  • [3] Advanced Glycation End Products, Soluble Receptor for Advanced Glycation End Products and Risk of Colorectal Cancer - A Prospective Cohort Study
    Jiao, Li
    Albanes, Demetrius
    Weinstein, Stephanie J.
    Graubard, Barry I.
    Taylor, Philip R.
    Virtamo, Jarmo
    Stolzenberg-Solomon, Rachael
    GASTROENTEROLOGY, 2010, 138 (05) : S18 - S18
  • [4] Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
    Jinluan Chen
    Banafsheh Arshi
    Komal Waqas
    Tianqi Lu
    Daniel Bos
    M. Arfan Ikram
    André G. Uitterlinden
    Maryam Kavousi
    M. Carola Zillikens
    Cardiovascular Diabetology, 22
  • [5] Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
    Chen, Jinluan
    Arshi, Banafsheh
    Waqas, Komal
    Lu, Tianqi
    Bos, Daniel
    Ikram, M. Arfan
    Uitterlinden, Andre G.
    Kavousi, Maryam
    Zillikens, M. Carola
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [6] Advanced glycation end products measured by skin autofluorescence in a population with central obesity
    den Engelsen, Corine
    van den Donk, Maureen
    Gorter, Kees J.
    Salome, Philippe L.
    Rutten, Guy E.
    DERMATO-ENDOCRINOLOGY, 2012, 4 (01) : 33 - 38
  • [7] Plasma advanced glycation end-products and skin autofluorescence are increased in COPD
    Gopal, Poornima
    Reynaert, Niki L.
    Scheijen, Jean L. J. M.
    Engelen, Lean
    Schalkwijk, Casper G.
    Franssen, Frits M. E.
    Wouters, Emiel F. M.
    Rutten, Erica P. A.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (02) : 430 - 438
  • [8] Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease
    Hartog, JWL
    De Vries, APJ
    Lutgers, HL
    Meerwaldt, R
    Huisman, RM
    Van Son, WJ
    De Jong, PE
    Smit, AJ
    MAILLARD REACTION: CHEMISTRY AT THE INTERFACE OF NUTRITION, AGING, AND DISEASE, 2005, 1043 : 299 - 307
  • [9] Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes
    Kouidrat, Youssef
    Zaitouni, Ahmad
    Amad, Ali
    Diouf, Momar
    Desailloud, Rachel
    Loas, Gwenole
    Lalau, Jean-Daniel
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (01) : 108 - 113
  • [10] Skin autofluorescence, reflecting accumulation of advanced glycation end products, and the risk of dementia in a population-based cohort
    Mooldijk, Sanne S.
    Lu, Tianqi
    Waqas, Komal
    Chen, Jinluan
    Vernooij, Meike W.
    Ikram, M. Kamran
    Zillikens, M. Carola
    Ikram, M. Arfan
    SCIENTIFIC REPORTS, 2024, 14 (01)